Evidence map›Paper›PMID 26429886›Full record

ArticleScience (New York, N.Y.)2015

Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.

Xaver Sewald, Mark S Ladinsky, Pradeep D Uchil, Jagadish Beloor, Ruoxi Pi, Christin Herrmann, Nasim Motamedi, Thomas T Murooka, Michael A Brehm, Dale L Greiner and 5 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 169 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Nonlytic Egress and Transmission in the Virus World.Annual review of biochemistry · 2025
    Review
  9. Human CD123Journal of virus eradication · 2025
    Article
  10. Article
  11. Graft-derived extracellular vesicles transport miRNAs to modulate macrophage polarization after heart transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  12. Exploring CD169Vaccines · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Xaver SewaldDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06510, USA.
Mark S Ladinsky *Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Pradeep D Uchil *Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06510, USA.
Jagadish BeloorDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.
Ruoxi PiDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06510, USA.
Christin HerrmannDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06510, USA.
Nasim MotamediDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.
Thomas T MurookaCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Michael A BrehmProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Dale L GreinerProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Leonard D ShultzThe Jackson Laboratory, Bar Harbor, ME 04609, USA..
Thorsten R MempelCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Pamela J BjorkmanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Priti KumarDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.
Walther MothesDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06510, USA.
Yale University · USCalifornia Institute of Technology · USMassachusetts General Hospital · USUniversity of Massachusetts Chan Medical School · USJackson Laboratory · US

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
X-ray Cryst. CoreP50GM082545 · NIGMS · UNIVERSITY OF UTAH · PI SUNDQUIST, WESLEY I. · 2007 to 2018
$51.1M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Visualizing Effects of Costimulation on Antiviral ImmunityP01AI078897 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2008 to 2012
$12.1M
P3: Chemokine-Mediated T Cell Trafficking in HIV Transmission and Immune ResponseP01AI112521 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2014 to 2018
$9.8M
Retrovirus cell-to-cell transmissionR01CA098727 · NCI · YALE UNIVERSITY · PI MOTHES, WALTHER H · 2003 to 2017
$4.5M
Generation and Function of NK Cell MemoryR01AI111595 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2013 to 2017
$4.1M
Migratory Properties of HIV-infected T cells in vivoR01AI097052 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MEMPEL, THORSTEN ROMAN · 2013 to 2016
$2.5M
In vivo genomic editing of hematopoietic cells for HIV resistanceR01AI112443 · NIAID · YALE UNIVERSITY · PI GLAZER, PETER M, KUMAR, PRITI · 2014 to 2017
$2.1M
Novel Strategies to Antagonize Cocaine-Enhanced HIV PathobiologyR01DA036298 · NIDA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GROOPMAN, JEROME E, MEMPEL, THORSTEN ROMAN · 2013 to 2017
$2.0M
Two-photon microscope for intravital imagingS10RR026697 · NCRR · YALE UNIVERSITY · PI MOTHES, WALTHER H · 2010 to 2010
$488k
NCI NIH HHS P30 CA016359NCI NIH HHS R01 CA098727NCRR NIH HHS S10 RR026697NIAID NIH HHS P01 AI078897NIAID NIH HHS P01 AI112521NIAID NIH HHS R01 AI097052NIAID NIH HHS R01 AI111595NIAID NIH HHS R01 AI112443NIDA NIH HHS R01 DA036298NIDDK NIH HHS P30 DK043351NIGMS NIH HHS P50 GM082545NIGMS NIH HHS P50GM082545
6 · The paper itself

Abstract

Dendritic cells can capture and transfer retroviruses in vitro across synaptic cell-cell contacts to uninfected cells, a process called trans-infection. Whether trans-infection contributes to retroviral spread in vivo remains unknown. Here, we visualize how retroviruses disseminate in secondary lymphoid tissues of living mice. We demonstrate that murine leukemia virus (MLV) and human immunodeficiency virus (HIV) are first captured by sinus-lining macrophages. CD169/Siglec-1, an I-type lectin that recognizes gangliosides, captures the virus. MLV-laden macrophages then form long-lived synaptic contacts to trans-infect B-1 cells. Infected B-1 cells subsequently migrate into the lymph node to spread the infection through virological synapses. Robust infection in lymph nodes and spleen requires CD169, suggesting that a combination of fluid-based movement followed by CD169-dependent trans-infection can contribute to viral spread.

Indexed as

Virus InternalizationAnimalsDendritic CellsHIV-1HIV InfectionsHumansLeukemia Virus, MurineLymph NodesLymphocytesMacrophagesMiceMice, Inbred C57BLMice, KnockoutRetroviridae InfectionsSialic Acid Binding Ig-like Lectin 1SpleenSialic Acid Binding Ig-like Lectin 1Siglec1 protein, mouse

Identifiers

PMID26429886
PMCPMC4651917
OpenAlexW2162938388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.